These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 35572580)

  • 1. Corrigendum: Children and Adults With Mild COVID-19: Dynamics of the Memory T Cell Response Up to 10 Months.
    Kaaijk P; Olivo Pimentel V; Emmelot ME; Poelen MCM; Cevirgel A; Schepp RM; den Hartog G; Reukers DFM; Beckers L; van Beek J; van Els CACM; Meijer A; Rots NY; de Wit J
    Front Immunol; 2022; 13():893720. PubMed ID: 35572580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Corrigendum: Distinct Immune Response at 1 Year Post-COVID-19 According to Disease Severity.
    Kang CK; Kim M; Hong J; Kim G; Lee S; Chang E; Choe PG; Kim NJ; Kim IS; Seo JY; Song D; Lee DS; Shin HM; Kim YW; Lee CH; Park WB; Kim HR; Oh MD
    Front Immunol; 2022; 13():929770. PubMed ID: 35686133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Corrigendum: Nasal Administration of Anti-CD3 Monoclonal Antibody (Foralumab) Reduces Lung Inflammation and Blood Inflammatory Biomarkers in Mild to Moderate COVID-19 Patients: A Pilot Study.
    Moreira TG; Matos KTF; De Paula GS; Santana TMM; Da Mata RG; Pansera FC; Cortina AS; Spinola MG; Baecher-Allan CM; Keppeke GD; Jacob J; Palejwala V; Chen K; Izzy S; Healey BC; Rezende RM; Dedivitis RA; Shailubhai K; Weiner HL
    Front Immunol; 2021; 12():815812. PubMed ID: 35095916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Corrigendum: Brief Research Report: Virus-Specific Humoral Immunity at Admission Predicts the Development of Respiratory Failure in Unvaccinated SARS-CoV-2 Patients.
    Tajuelo A; Carretero O; García-Ríos E; López-Siles M; Cano O; Vázquez M; Más V; Rodríguez-Goncer I; Lalueza A; López-Medrano F; San Juan R; Fernández-Ruiz M; Aguado JM; McConnell MJ; Pérez-Romero P
    Front Immunol; 2022; 13():965809. PubMed ID: 35990649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Corrigendum: Impact of Hydroxychloroquine on Antibody Responses to the SARS-CoV-2 Coronavirus.
    Santos IKFM; Costa CHN
    Front Immunol; 2020; 11():615628. PubMed ID: 33224154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mild Cytokine Elevation, Moderate CD4
    Jia R; Wang X; Liu P; Liang X; Ge Y; Tian H; Chang H; Zhou H; Zeng M; Xu J
    Virol Sin; 2020 Dec; 35(6):734-743. PubMed ID: 32699972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Corrigendum: Experimental validation of immunogenic SARS-CoV-2 T cell epitopes identified by artificial intelligence.
    Federico L; Malone B; Tennøe S; Chaban V; Osen JR; Gainullin M; Smorodina E; Kared H; Akbar R; Greiff V; Stratford R; Clancy T; Munthe LA
    Front Immunol; 2024; 15():1377041. PubMed ID: 38449865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Corrigendum: ACTIVATE-2: A double-blind randomized trial of BCG vaccination against COVID-19 in individuals at risk.
    Tsilika M; Taks E; Dolianitis K; Kotsaki A; Leventogiannis K; Damoulari C; Kostoula M; Paneta M; Adamis G; Papanikolaou I; Stamatelopoulos K; Bolanou A; Katsaros K; Delavinia C; Perdios I; Pandi A; Tsiakos K; Proios N; Kalogianni E; Delis I; Skliros E; Akinosoglou K; Perdikouli A; Poulakou G; Milionis H; Athanassopoulou E; Kalpaki E; Efstratiou L; Perraki V; Papadopoulos A; Netea MG; Giamarellos-Bourboulis EJ
    Front Immunol; 2022; 13():1018384. PubMed ID: 36119100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Corrigendum: Protecting the vulnerable: addressing the COVID-19 care needs of people with compromised immunity.
    Razonable RR
    Front Immunol; 2024; 15():1440571. PubMed ID: 39119333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SARS-CoV-2 antibody dynamics and B-cell memory response over time in COVID-19 convalescent subjects.
    Achiron A; Gurevich M; Falb R; Dreyer-Alster S; Sonis P; Mandel M
    Clin Microbiol Infect; 2021 Sep; 27(9):1349.e1-1349.e6. PubMed ID: 33975009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SARS-CoV-2-specific B- and T-cell immunity in a population-based study of young Swedish adults.
    Björkander S; Du L; Zuo F; Ekström S; Wang Y; Wan H; Sherina N; Schoutens L; Andréll J; Andersson N; Georgelis A; Bergström A; Marcotte H; Kull I; Hammarström L; Melén E; Pan-Hammarström Q;
    J Allergy Clin Immunol; 2022 Jan; 149(1):65-75.e8. PubMed ID: 34695490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Corrigendum: Case report: Persistence of residual antigen and RNA of the SARS-CoV-2 virus in tissues of two patients with long COVID.
    Goh D; Lim JCT; Fernaíndez SB; Joseph CR; Edwards SG; Neo ZW; Lee JN; Caballero SG; Lau MC; Yeong JPS
    Front Immunol; 2022; 13():1036894. PubMed ID: 36275692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Corrigendum: Neuro-PASC is characterized by enhanced CD4+ and diminished CD8+ T cell responses to SARSCoV-2 Nucleocapsid protein.
    Visvabharathy L; Hanson BA; Orban ZS; Lim PH; Palacio NM; Jimenez M; Clark JR; Graham EL; Liotta EM; Tachas G; Penaloza-MacMaster P; Koralnik IJ
    Front Immunol; 2023; 14():1275925. PubMed ID: 37691950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Corrigendum: The effects of COVID-19 on the placenta during pregnancy.
    Rad HS; Röhl J; Stylianou N; Allenby MC; Bazaz SR; Warkiani ME; Guimaraes FSF; Clifton VL; Kulasinghe A
    Front Immunol; 2022; 13():998406. PubMed ID: 36159853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Corrigendum: The Adipocyte and Adaptive Immunity.
    Song J; Deng T
    Front Immunol; 2021; 12():784125. PubMed ID: 34691088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Corrigendum: Brief research report: impact of vaccination on antibody responses and mortality from severe COVID-19.
    Adhikari B; Bednash JS; Horowitz JC; Rubinstein MP; Vlasova AN
    Front Immunol; 2024; 15():1384209. PubMed ID: 38482012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune Memory in Mild COVID-19 Patients and Unexposed Donors Reveals Persistent T Cell Responses After SARS-CoV-2 Infection.
    Ansari A; Arya R; Sachan S; Jha SN; Kalia A; Lall A; Sette A; Grifoni A; Weiskopf D; Coshic P; Sharma A; Gupta N
    Front Immunol; 2021; 12():636768. PubMed ID: 33777028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Corrigendum: The role of peroxisome proliferator-activated receptors in the modulation of hyperinflammation induced by SARS-CoV-2 infection: A perspective for COVID-19 therapy.
    Hasankhani A; Bahrami A; Tavakoli-Far B; Iranshahi S; Ghaemi F; Akbarizadeh MR; Amin AH; Abedi Kiasari B; Mohammadzadeh Shabestari A
    Front Immunol; 2024; 15():1422261. PubMed ID: 38779659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of SARS-CoV-2 Immunity in Convalescent Children and Adolescents.
    Tsang HW; Chua GT; To KKW; Wong JSC; Tu W; Kwok JSY; Wong WHS; Wang X; Zhang Y; Rosa Duque JS; Chan GCF; Chu WK; Pang CP; Tam PKH; Lau YL; Wong ICK; Leung WH; Yuen KY; Kwan MYW; Ip P
    Front Immunol; 2021; 12():797919. PubMed ID: 34975908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Longitudinal Analysis of Human Memory T-Cell Response According to the Severity of Illness up to 8 Months After Severe Acute Respiratory Syndrome Coronavirus 2 Infection.
    Kang CK; Kim M; Lee S; Kim G; Choe PG; Park WB; Kim NJ; Lee CH; Kim IS; Jung K; Lee DS; Shin HM; Kim HR; Oh MD
    J Infect Dis; 2021 Jul; 224(1):39-48. PubMed ID: 33755725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.